- Home
- CNVS vs KYNB Comparison
CNVS vs KYNB Comparison
Compare CNVS & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNVS | KYNB |
|---|---|---|
| Founded | 2000 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.5M | 31.9M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNVS | KYNB |
|---|---|---|
| Price | $3.01 | $6.91 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 449.5K | 39.4K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 108.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $78,181,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $84.42 | N/A |
| P/E Ratio | ★ N/A | $0.15 |
| Revenue Growth | ★ 59.13 | N/A |
| 52 Week Low | $1.77 | $6.72 |
| 52 Week High | $7.39 | $9.58 |
Technical Indicators
Market Signals| Indicator | CNVS | KYNB |
|---|---|---|
| Relative Strength Index (RSI) | 64.70 | 38.95 |
| Support Level | $2.37 | N/A |
| Resistance Level | $3.49 | $8.89 |
| Average True Range (ATR) | 0.30 | 0.49 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 74.40 | 12.33 |
Price Performance
Historical ComparisonAbout CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.
About KYNB Kyntra Bio Inc. Common Stock
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.